The Diabetes Forum Support Community For Diabetics Online banner
1 - 2 of 2 Posts

34 Posts
Discussion Starter · #1 ·
Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, announced completion of treatment in an 80 patient multi-center open label, randomized, parallel group Phase II study in India to determine the safety and efficacy of add-on intranasal insulin spray (Nasulin?) in patients with type 2 diabetes mellitus on oral anti-diabetic therapy. The clinical study report is expected to be completed later this month, but preliminary clinical results are being released today.
for more info, visit:
Bentley Pharmaceuticals Announces Completion Of Treatment In Phase II India Clinical Study In Type 2 Diabetes And Preliminary Clinical Results
1 - 2 of 2 Posts
This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.